As an ISCRM REU Fellow, Birva Pinto will investigate the genetic mutation G159D in cardiac troponin C (cTnC) related to Dilated Cardiomyopathy (DCM), a disease that enlarges the heart chambers, reduces its pumping capacity, and potentially leads to heart failure. She will also test how both mutant and wild-type cTnC respond to a troponin-activating drug. The goal is to uncover insights into the pathogenesis of DCM and contribute to potential therapeutic treatments.